| Name | Title | Contact Details |
|---|
Encora is a leader in the large and rapidly growing outsourced product development market. We partner primarily with fast growing tech companies who are driving innovation and growth within their industries. Through proprietary agile development capabilities, deep micro-industry vertical expertise and a global talent pool, we drive transformational outcomes for clients. Encora provides differentiated innovation services and software engineering solutions across a wide range of leading-edge technologies, including Big Data, analytics, machine learning, IoT, mobile, cloud, UI/UX, and test automation. Our unique delivery model, agile methodology, and consistent unmatched quality have contributed to our steady growth over the years. We use agile development methods to apply these tools across many tech-enabled industries, including Fast Growing Tech, FinTech, Security, HealthTech, Travel and Digital Commerce. Over many years, Encora has developed the proprietary EDC (Extended Delivery Center) framework to accelerate innovation for clients. One of the unique characteristics of this model is the seamless extension of clients` development team, internal processes and even their culture. This improves quality of engineering, team throughput and speed to impact. Our greatest strength is the passion of our people. The energy and creativity they bring to their work every day is truly inspiring, and it drives the innovation we deliver for our clients. Our people are the primary reason Encora is such a great place to work.
IdentifySensors is a leading developer of digital diagnostic technologies on graphene-based biosensors. The company is principally focused on developing real-time pathogen detection capabilities for direct diagnosis and remote monitoring. The company`s technology has expanded into multiple industries and applications, such as pathogen diagnostics and testing for food contamination. Check4® by IdentifySensors Biologics® is a next-generation digital diagnostic platform intended to detect multiple pathogens within 5 minutes at the molecular gene level. The platform is intended to eliminates the need for enzymatic amplification and reagents. Graphene sensor technology has moved diagnostics beyond chemical testing into a rapid digital platform intended to be as accurate as a PCR test but significantly more sensitive and cost effective. Printed graphene sensors isolate targeted viruses and bacteria from saliva and other bodily fluids within a handheld, Bluetooth device. The platform is intended to detect the genetic material of dozens of pathogens for over-the-counter and point-of-care use. With a target price at a fraction of current molecular tests, Check4® is intended to disrupt the PCR market for many infections. The Check4® testing platform comes is two main parts: 1) A reader, which connects to a user`s cell phone or to a clinical database; and 2) Single-use test cartridges, which can contain multiple graphene sensors to detect multiple infections. The reader, which can be reused thousands of times, serves as the base of the platform, accepting any number of test cartridges. Disposable test cartridges, which require the reader to work, will be sold separately.
Agrizzi Enterprises Corporation is a Miami, FL-based company in the Computers and Electronics sector.
INTEG Process Group is a Wexford, PA-based company in the Computers and Electronics sector.
Conway Dierking and Hilman is a Grand Rapids, MI-based company in the Computers and Electronics sector.